Bashir Mustafa R, Horowitz Jeanne M, Kamel Ihab R, Arif-Tiwari Hina, Asrani Sumeet K, Chernyak Victoria, Goldstein Alan, Grajo Joseph R, Hindman Nicole M, Kamaya Aya, McNamara Michelle M, Porter Kristin K, Solnes Lilja Bjork, Srivastava Pavan K, Zaheer Atif, Carucci Laura R
Duke University Medical Center, Durham, North Carolina.
Panel Vice Chair, Northwestern University, Chicago, Illinois.
J Am Coll Radiol. 2020 May;17(5S):S70-S80. doi: 10.1016/j.jacr.2020.01.023.
The liver fibrosis stage is the most important clinical determinate of morbidity and mortality in patients with chronic liver diseases. With newer therapies, liver fibrosis can be stabilized and possibly reversed, thus accurate diagnosis and staging of liver fibrosis are clinically important. Ultrasound, CT, and conventional MRI can be used to establish the diagnosis of advanced fibrosis/cirrhosis but have limited utility for assessing earlier stages of fibrosis. Elastography-based ultrasound and MRI techniques are more useful for assessment of precirrhotic hepatic fibrosis. In patients with advanced fibrosis at risk for hepatocellular carcinoma (HCC), ultrasound is the surveillance modality recommended by international guidelines in nearly all circumstances. However, in patients in whom ultrasound does not assess the liver well, including those with severe steatosis or obesity, multiphase CT or MRI may have a role in surveillance for HCC. Both multiphase CT and MRI can be used for continued surveillance in patients with a history of HCC, and contrast-enhanced ultrasound may have an emerging role in this setting. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
肝纤维化阶段是慢性肝病患者发病率和死亡率的最重要临床决定因素。随着新型疗法的出现,肝纤维化可以得到稳定甚至逆转,因此肝纤维化的准确诊断和分期具有重要的临床意义。超声、CT和传统MRI可用于诊断晚期纤维化/肝硬化,但在评估早期纤维化阶段的作用有限。基于弹性成像的超声和MRI技术在评估肝硬化前期肝纤维化方面更有用。在有肝细胞癌(HCC)风险的晚期纤维化患者中,超声几乎是国际指南在所有情况下推荐的监测方式。然而,在超声对肝脏评估不佳的患者中,包括那些有严重脂肪变性或肥胖的患者,多期CT或MRI可能在HCC监测中发挥作用。多期CT和MRI均可用于有HCC病史患者的持续监测,对比增强超声在这种情况下可能会发挥越来越重要的作用。美国放射学会适宜性标准是针对特定临床情况的循证指南,每年由多学科专家小组进行审查。指南的制定和修订包括对同行评审期刊上的当前医学文献进行广泛分析,并应用成熟的方法(兰德/加州大学洛杉矶分校适宜性方法和推荐评估、制定和评价分级或GRADE)来评估特定临床场景下成像和治疗程序的适宜性。在缺乏证据或证据不明确的情况下,专家意见可能会补充现有证据以推荐成像或治疗。